Company research
Pulmonx Corp
CIK 1127537Updated Sep 24, 2026
SecurityLUNG · NASDAQ · equity
Name history
PULMONX · through Feb 7, 2012
LUNG price & chart
Loading TradingView…
NASDAQ:LUNG on TradingView ↗In the news
Pulmonx to Participate in Upcoming Investor Conferences ↗
Recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 129,291,000Source | 162,850,000Source | 177,781,000Source | 193,676,000Source |
| Property, Plant and Equipment, NetUSD | 2,220,000Source | 2,907,000Source | 4,028,000Source | 4,694,000Source |
| GoodwillUSD | 2,333,000Source | 2,333,000Source | 2,333,000Source | 2,333,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 69,751,000Source | 70,905,000Source | 83,547,000Source | 101,736,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 12,072,000Source | 13,120,000Source | 12,105,000Source | 8,677,000Source |
| Inventory, NetUSD | 15,845,000Source | 16,915,000Source | 16,743,000Source | 14,564,000Source |
| Assets, CurrentUSD | 101,684,000Source | 136,248,000Source | 150,422,000Source | 168,953,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 3,758,000Source | 4,474,000Source | 4,235,000Source | 4,343,000Source |
| Operating Lease, Right-of-Use AssetUSD | 18,028,000Source | 18,545,000Source | 3,406,000Source | 5,806,000Source |
| Other Assets, NoncurrentUSD | 1,422,000Source | 1,136,000Source | 591,000Source | 529,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 75,175,000Source | 77,041,000Source | 59,466,000Source | 39,669,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 42,000Source | 40,000Source | 39,000Source | 38,000Source |
| Retained Earnings (Accumulated Deficit)USD | -521,558,000Source | -467,555,000Source | -411,161,000Source | -350,318,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 2,360,000Source | 2,113,000Source | 2,640,000Source | 1,575,000Source |
| Stockholders' Equity Attributable to ParentUSD | 54,116,000Source | 85,809,000Source | 118,315,000Source | 154,007,000Source |
| Additional Paid in Capital, Common StockUSD | 573,272,000Source | 551,211,000Source | 526,797,000Source | 502,712,000Source |
| Liabilities and EquityUSD | 129,291,000Source | 162,850,000Source | 177,781,000Source | 193,676,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 20,058,000Source | 24,437,000Source | 23,157,000Source | 18,492,000Source |
| Operating Lease, Liability, CurrentUSD | 1,210,000Source | 778,000Source | 3,074,000Source | 3,229,000Source |
| Accounts Payable, CurrentUSD | 3,905,000Source | 3,827,000Source | 1,497,000Source | 1,758,000Source |
| Operating Lease, Liability, NoncurrentUSD | 18,059,000Source | 18,515,000Source | 1,106,000Source | 3,849,000Source |
| Deferred Income Tax Liabilities, NetUSD | 69,000Source | 87,000Source | 114,000Source | 94,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 14,556,000Source | 16,472,000Source | 16,234,000Source | 13,276,000Source |
| Deferred Tax Liabilities, NetUSD | 69,000Source | 87,000Source | 114,000Source | 94,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | — | — | — | 17,324,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 36,989,000Source | 34,002,000Source | 35,089,000Source | — |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation and amortization | — | — | — | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 21,233,000Source | 22,955,000Source | 22,101,000Source | 16,445,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | -1,075,000Source | 1,308,000Source | 3,104,000Source | 2,190,000Source |
| Increase (Decrease) in InventoriesUSD | 765,000Source | 229,000Source | -918,000Source | 3,638,000Source |
| Increase (Decrease) in Accounts PayableUSD | 270,000Source | 2,278,000Source | -345,000Source | 247,000Source |
| Deferred Income Tax Expense (Benefit)USD | -19,000Source | -24,000Source | 26,000Source | 55,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -32,376,000Source | -31,537,000Source | -37,610,000Source | -45,083,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 30,482,000Source | 17,476,000Source | -2,007,000Source | -4,225,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 452,000Source | 1,447,000Source | 807,000Source | 1,318,000Source |
| Cash flows from financing activities: | ||||
| Payments for Repurchase of Common StockUSD | — | — | 0Source | 27,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 833,000Source | 1,363,000Source | 21,400,000Source | 2,419,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -1,153,000Source | -12,622,000Source | -18,183,000Source | -46,744,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 70,009,000Source | 71,162,000Source | 83,784,000Source | 101,967,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 3,113,000Source | 3,482,000Source | 2,984,000Source | 847,000Source |
| Income Taxes Paid, NetUSD | 468,000Source | 556,000Source | 471,000Source | 398,000Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | -92,000Source | 76,000Source | 34,000Source | 145,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 21,233,000Source | 22,955,000Source | 22,101,000Source | 16,445,000Source |
| Amortization of Debt Issuance Costs and DiscountsUSD | 53,000Source | 52,000Source | 48,000Source | 56,000Source |
| Amortization of Intangible AssetsUSD | — | 100,000Source | 100,000Source | 100,000Source |
| DepreciationUSD | 1,100,000Source | 1,100,000Source | 1,400,000Source | 1,400,000Source |
| Foreign Currency Transaction Gain (Loss), RealizedUSD | 700,000Source | 100,000Source | -800,000Source | -400,000Source |
| Gain (Loss) on Disposition of AssetsUSD | — | 0Source | 15,000Source | — |
| GoodwillUSD | 2,333,000Source | 2,333,000Source | 2,333,000Source | 2,333,000Source |
| Income Tax Expense (Benefit)USD | 626,000Source | 500,000Source | 571,000Source | 353,000Source |
| InterestExpenseNonoperatingUSD | 3,155,000Source | 3,507,000Source | — | — |
| Inventory Write-downUSD | 143,000Source | 75,000Source | 507,000Source | 485,000Source |
| Investment Income, InterestUSD | 2,651,000Source | 5,061,000Source | 5,568,000Source | 1,529,000Source |
| Net Income (Loss) Attributable to ParentUSD | -54,003,000Source | -56,394,000Source | -60,843,000Source | -58,923,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -54,003,000Source | -56,394,000Source | -60,843,000Source | -58,923,000Source |
| Operating ExpensesUSD | 120,802,000Source | 119,705,000Source | 112,687,000Source | 98,502,000Source |
| Other Nonoperating Income (Expense)USD | 790,000Source | 256,000Source | -673,000Source | -396,000Source |
| Proceeds from Issuance of Long-term DebtUSD | — | 0Source | 20,000,000Source | — |
| Proceeds from Stock Options ExercisedUSD | 249,000Source | 218,000Source | 310,000Source | 644,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 90,497,000Source | 83,789,000Source | 68,675,000Source | 53,662,000Source |
| Cost of RevenueUSD | 23,358,000Source | 21,788,000Source | 17,923,000Source | 13,797,000Source |
| Selling, General and Administrative ExpenseUSD | 101,311,000Source | 102,135,000Source | 94,607,000Source | 83,105,000Source |
| Operating Income (Loss)USD | -53,663,000Source | -57,704,000Source | -61,935,000Source | -58,637,000Source |
| Other Nonoperating Income (Expense)USD | 790,000Source | 256,000Source | -673,000Source | -396,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -53,377,000Source | -55,894,000Source | -60,272,000Source | -58,570,000Source |
| Income Tax Expense (Benefit)USD | 626,000Source | 500,000Source | 571,000Source | 353,000Source |
| Net Income (Loss) Attributable to ParentUSD | -54,003,000Source | -56,394,000Source | -60,843,000Source | -58,923,000Source |
| Earnings Per Share, BasicUSD per share | -1.33Source | -1.44Source | -1.6Source | -1.59Source |
| Earnings Per Share, DilutedUSD per share | -1.33Source | -1.44Source | -1.6Source | -1.59Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 40,685,934Source | 39,111,073Source | 37,974,567Source | 37,096,541Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 40,685,934Source | 39,111,073Source | 37,974,567Source | 37,096,541Source |
| Interest Expense (non-operating)USD | 3,155,000Source | 3,507,000Source | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | — | 100,000Source | 100,000Source | 100,000Source |
| Current Income Tax Expense (Benefit)USD | 645,000Source | 524,000Source | 545,000Source | 298,000Source |
| Foreign Currency Transaction Gain (Loss), RealizedUSD | 700,000Source | 100,000Source | -800,000Source | -400,000Source |
| Gross ProfitUSD | 67,139,000Source | 62,001,000Source | 50,752,000Source | 39,865,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -57,077,000Source | -57,570,000Source | -60,503,000Source | -59,361,000Source |
| Interest ExpenseUSD | — | — | 3,232,000Source | 1,066,000Source |
| Investment Income, InterestUSD | 2,651,000Source | 5,061,000Source | 5,568,000Source | 1,529,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -54,003,000Source | -56,394,000Source | -60,843,000Source | -58,923,000Source |
| Operating ExpensesUSD | 120,802,000Source | 119,705,000Source | 112,687,000Source | 98,502,000Source |
| Research and Development ExpenseUSD | 19,491,000Source | 17,570,000Source | 18,080,000Source | 15,397,000Source |